<DOC>
	<DOCNO>NCT00775762</DOCNO>
	<brief_summary>This monocentric , randomize , open study assess anti-inflammatory anti-platelet effect Clopidogrel aspirin versus aspirin clopidogrel alone patient symptomatic polyvascular disease multiple recurrent cardiovascular event .</brief_summary>
	<brief_title>Anti-Inflammatory Anti-Platelet Effect Clopidogrel Aspirin v Aspirin Alone Symptomatic Polyvascular Disease Patients With Multiple Recurrent Cardiovascular Events</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients symptomatic polyvascular disease recurrent cardiovascular event . In particular patient establish stable coronary artery disease associate peripheral disease cerebrovascular disease patient two acute cardiovascular event . chronic treatment anticoagulant drug use antiplatelet therapy ; intolerance/allergy Aspirin Clopidogrel platelet count outside range 125450 10^9/l inflammatory infectious disease malignancy immunologic hematological disorder .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Symptomatic Polyvascular disease</keyword>
	<keyword>Multiple recurrent cardiovascular event</keyword>
</DOC>